KDM2A和KDM2B保护CpG群岛的一个子集免受DNA甲基化
Yuan Liu1, Ying Liu1, Yunji Zhu1
1State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Journal of genetics and genomics = Yi chuan xue bao
|November 10, 2024
概括
通过去除H3K36me2标记,KDM2A和KDM2B蛋白在CpG岛屿 (CGI) 中保持低DNA甲基化. 它们的耗尽增加了CGI甲基化,揭示了基因表达中的冗余,脱甲基化依赖的调节作用.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 哺乳动物基因组中的大多数CpG都是甲基化的.
- CpG 岛屿 (CGI) 在很大程度上没有甲基化,对基因表达至关重要.
- 维持低CGI甲基化的机制尚不清楚.
研究的目的:
- 研究KDM2蛋白在CGI调节DNA甲基化中的作用.
- 为了确定KDM2A和KDM2B是否冗余地控制CGI甲基化.
- 阐明KDM2介导的CGI甲基化调节的机制.
主要方法:
- 通过基因操纵减少KDM2A和KDM2B蛋白质的含量.
- 在KDM2蛋白中JmjC域的突变,取消脱甲基化活性.
- 在选择性CGI中分析DNA甲基化水平.
- 评估CGI甲基化变化与染色质环境之间的关联.
主要成果:
- 由于KDM2蛋白质的枯竭或功能性失活,在特定的CGI增加了DNA甲基化.
- KDM2A和KDM2B表现出冗余的作用,双重淘汰表现出更明显的甲基化增加.
- 观察到的CGI甲基化增加与染色质环境的变化有关.
- KDM2蛋白调节CGIDNA甲基化,这种方式取决于H3K36me2的脱甲基化.
结论:
- KDM2A和KDM2B在CGI的一个子集上冗余调节DNA甲基化.
- 这种调节取决于它们的H3K36me2脱甲基酶活性.
- KDM2蛋白质在维持CGI的低甲基化中发挥着关键作用,影响基因调节.
相关概念视频
01:46Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
02:25Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:38S-Cdk Initiates DNA Replication
4.7K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.7K
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K